ArticleGynecologic oncology reports2025
Identification of low-risk cases of invasive endocervical adenocarcinoma with Silva pattern-based classification: a systematic review and
Article in Gynecologic oncology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: We aimed to describe the discriminatory ability of the Silva pattern-based classification system for invasive endocervical adenocarcinoma (EAC) in predicting risks of lymph node (LN) metastasis, recurrence, and death. Method: We systematically searched PubMed, Scopus, and Embase through 2024 for manuscripts describing patients with EAC by Silva pattern-based classification. We included studies reporting outcomes of LN metastasis, recurrence, or death by Silva pattern. Random-effects Results: We identified 19 studies including 2998 patients (20.8 % pattern A, 23.1 % pattern B, 54.1 % pattern C). Silva pattern A cases showed a significantly lower risk of LN metastasis (3/509; 0.6 %) than pattern B (6.1 %; OR = 0.33, 95 %CI 0.16-0.67) or pattern C (22.0 %; OR = 0.09; 95 %CI 0.05-0.16). Across 5 studies limited to stage I disease, there were no Silva pattern A cases with LN metastasis, recurrence, or death. Among 11 studies reporting on recurrence and death, Silva pattern A cases had distinctly low risk of 0.3 % for both outcomes, including a significantly lower risk of recurrence (OR = 0.15, 95 %CI 0.06-0.34) and death (OR = 0.21, 95 %CI 0.09-0.50) versus patterns B/C. Silva pattern B cases showed significantly lower risk of all outcomes compared with pattern C. Conclusions: We demonstrate that Silva classification is highly predictive of oncologic outcomes for EAC, with patterns A, B, and C showing distinct low, intermediate, and high risk profiles. The low risk profile of pattern A may justify future prospective study of surgical and adjuvant treatment de-escalation from the current standard of care, while pattern C cases may warrant consideration of adjuvant treatment escalation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.